Literature DB >> 16920025

Pathogen-derived immunomodulatory molecules: future immunotherapeutics?

Padraic G Fallon1, Antonio Alcami.   

Abstract

The identification of molecules from various pathogens that modulate innate and/or adaptive immunity is a dynamic and rapidly developing area of research. These immunomodulatory molecules (IM) have been optimized during pathogen-host co-evolution, and have a potential application as novel immunotherapeutics. In this review, we illustrate the use of pathogen IM that have been produced as recombinant proteins, with different modes of modulatory activity, and discuss their potential to modulate undesirable immune responses in human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920025     DOI: 10.1016/j.it.2006.08.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  26 in total

1.  Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.

Authors:  Isaac G Sakala; Geeta Chaudhri; R Mark Buller; Anthony A Nuara; Hongdong Bai; Nanhai Chen; Gunasegaran Karupiah
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.

Authors:  M Begoña Ruiz-Argüello; Vincent P Smith; Gabriele S V Campanella; Françoise Baleux; Fernando Arenzana-Seisdedos; Andrew D Luster; Antonio Alcami
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

3.  Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Authors:  Harry Sokol; Nadia Vasquez; Nadia Hoyeau-Idrissi; Philippe Seksik; Laurent Beaugerie; Anne Lavergne-Slove; Philippe Pochart; Philippe Marteau
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

4.  Molecular and functional characterization of macrophage migration inhibitory factor (MIF) homolog of human from lymphatic filarial parasite Wuchereria bancrofti.

Authors:  Rohit Sharma; S L Hoti; R L Meena; V Vasuki; T Sankari; P Kaliraj
Journal:  Parasitol Res       Date:  2012-08-09       Impact factor: 2.289

5.  Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?

Authors:  Jane A Leopold
Journal:  Circ Cardiovasc Interv       Date:  2010-12       Impact factor: 6.546

Review 6.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

7.  Vaccinia virus A43R gene encodes an orthopoxvirus-specific late non-virion type-1 membrane protein that is dispensable for replication but enhances intradermal lesion formation.

Authors:  Cindy L Sood; Bernard Moss
Journal:  Virology       Date:  2009-11-08       Impact factor: 3.616

8.  Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10.

Authors:  Lucila G G Pacífico; Fábio A V Marinho; Cristina T Fonseca; Michele M Barsante; Vanessa Pinho; Policarpo A Sales-Junior; Luciana S Cardoso; Maria Ilma Araújo; Edgar M Carvalho; Geovanni D Cassali; Mauro M Teixeira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.

Authors:  Mattias Collin; Oonagh Shannon; Lars Björck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

10.  Sorting Motifs in the Cytoplasmic Tail of the Immunomodulatory E3/49K Protein of Species D Adenoviruses Modulate Cell Surface Expression and Ectodomain Shedding.

Authors:  Mark Windheim; Stefan Höning; Keith N Leppard; Larissa Butler; Christina Seed; Sreenivasan Ponnambalam; Hans-Gerhard Burgert
Journal:  J Biol Chem       Date:  2016-02-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.